Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.

We developed eight new antibodies against lipoprotein lipase (LPL), which included polyclonal antibodies raised against recombinant human LPL produced by transformant cells and two synthetic peptides corresponding to either amino (N)- or carboxy (C)-terminus of human LPL. With these antibodies, we e...

Full description

Bibliographic Details
Main Authors: M Kawamura, T Gotoda, N Mori, H Shimano, K Kozaki, K Harada, M Shimada, T Inaba, Y Watanabe, Y Yazaki
Format: Article
Language:English
Published: Elsevier 1994-09-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520411666
id doaj-c0b7386079e040fe9ccb0e730640cf76
record_format Article
spelling doaj-c0b7386079e040fe9ccb0e730640cf762021-04-26T05:51:56ZengElsevierJournal of Lipid Research0022-22751994-09-0135916881697Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.M Kawamura0T Gotoda1N Mori2H Shimano3K Kozaki4K Harada5M Shimada6T Inaba7Y Watanabe8Y Yazaki9Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.We developed eight new antibodies against lipoprotein lipase (LPL), which included polyclonal antibodies raised against recombinant human LPL produced by transformant cells and two synthetic peptides corresponding to either amino (N)- or carboxy (C)-terminus of human LPL. With these antibodies, we established three effective sandwich enzyme-linked immunosorbent assays (ELISAs) for LPL, which enabled us to examine LPL mass not only in the postheparin plasma from human, rat, mouse, and guinea pig but also in the media and lysates of cultured cells. All of the developed antibodies showed high affinities for LPL, but their binding to LPL did not always influence the lipolytic activity of the enzyme. Interestingly, although the anti-C-terminus antibody should bind to a common epitope of human and mouse LPL, its binding selectively suppressed only human LPL activity. Because amino acid sequence surrounding the epitope is common to both LPLs, difference in the sequence outside the epitope will contribute to the selective suppression of LPL activity by the antibody. Our results also suggested that both termini of LPL would be exposed on the surface of the molecule because they were fully accessible to antibodies and that the N-terminus of LPL would be functionally less important because binding of the anti-N-terminus antibody did not affect human LPL activity. The ELISAs were further utilized to demonstrate the presence of C-terminus truncated LPL protein in the postheparin plasma of an LPL-deficient patient, to map an epitope of the anti-C-terminus antibody within residues 433-436, and to gain insight into the structure-function relationship of the LPL molecule.(ABSTRACT TRUNCATED AT 250 WORDS)http://www.sciencedirect.com/science/article/pii/S0022227520411666
collection DOAJ
language English
format Article
sources DOAJ
author M Kawamura
T Gotoda
N Mori
H Shimano
K Kozaki
K Harada
M Shimada
T Inaba
Y Watanabe
Y Yazaki
spellingShingle M Kawamura
T Gotoda
N Mori
H Shimano
K Kozaki
K Harada
M Shimada
T Inaba
Y Watanabe
Y Yazaki
Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
Journal of Lipid Research
author_facet M Kawamura
T Gotoda
N Mori
H Shimano
K Kozaki
K Harada
M Shimada
T Inaba
Y Watanabe
Y Yazaki
author_sort M Kawamura
title Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
title_short Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
title_full Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
title_fullStr Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
title_full_unstemmed Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
title_sort establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies.
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1994-09-01
description We developed eight new antibodies against lipoprotein lipase (LPL), which included polyclonal antibodies raised against recombinant human LPL produced by transformant cells and two synthetic peptides corresponding to either amino (N)- or carboxy (C)-terminus of human LPL. With these antibodies, we established three effective sandwich enzyme-linked immunosorbent assays (ELISAs) for LPL, which enabled us to examine LPL mass not only in the postheparin plasma from human, rat, mouse, and guinea pig but also in the media and lysates of cultured cells. All of the developed antibodies showed high affinities for LPL, but their binding to LPL did not always influence the lipolytic activity of the enzyme. Interestingly, although the anti-C-terminus antibody should bind to a common epitope of human and mouse LPL, its binding selectively suppressed only human LPL activity. Because amino acid sequence surrounding the epitope is common to both LPLs, difference in the sequence outside the epitope will contribute to the selective suppression of LPL activity by the antibody. Our results also suggested that both termini of LPL would be exposed on the surface of the molecule because they were fully accessible to antibodies and that the N-terminus of LPL would be functionally less important because binding of the anti-N-terminus antibody did not affect human LPL activity. The ELISAs were further utilized to demonstrate the presence of C-terminus truncated LPL protein in the postheparin plasma of an LPL-deficient patient, to map an epitope of the anti-C-terminus antibody within residues 433-436, and to gain insight into the structure-function relationship of the LPL molecule.(ABSTRACT TRUNCATED AT 250 WORDS)
url http://www.sciencedirect.com/science/article/pii/S0022227520411666
work_keys_str_mv AT mkawamura establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT tgotoda establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT nmori establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT hshimano establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT kkozaki establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT kharada establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT mshimada establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT tinaba establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT ywatanabe establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
AT yyazaki establishmentofenzymelinkedimmunosorbentassaysforlipoproteinlipasewithnewlydevelopedantibodies
_version_ 1721508303552380928